RecruitingNCT04612296
The Heart Hive - Cardiomyopathy Study
A Longitudinal Observational Study of Self-reported Cardiomyopathy in the Heart Hive
Sponsor
Imperial College London
Enrollment
10,000 participants
Start Date
Nov 9, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of cardiomyopathies.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Adult (age 18 and over),
- Males and Females,
- Capacity to provide informed consent,
- Patients with a confirmed diagnosis of cardiomyopathy or myocarditis,
- People with a family history of cardiomyopathy confirmed in a first or second degree relative.
- Note: Pregnant women are eligible. This study is observational and entirely separate from clinical care.
Exclusion Criteria7
- Patients who lack capacity to consent for themselves,
- Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill).
- Patients with a confirmed history of coronary artery disease:
- who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or
- who have undergone previous percutaneous coronary intervention or coronary bypass surgery
- History of primary valvular heart disease or congenital heart disease
- Severe, untreated or untreatable hypertension (systolic blood pressures routinely \>180 mm Hg and/or diastolic blood pressures \>120 mm Hg)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
GENETICResearch genetic analysis
Genetic analysis of DNA extracted from saliva. Participants can opt in to receive individual results of research genetic analysis for a predefined panel of clinically actionable cardiomyopathy genes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04612296
Related Trials
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
NCT0589071614 locations
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
NCT053022711 location
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT0656389598 locations
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
NCT0503443219 locations
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
NCT048433713 locations